Please visit answersincme.com/CTR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonary infections and vaccination discusses the rationale for respiratory syncytial virus (RSV) vaccination in older adults and how late-stage emerging vaccines can lower their risk of RSV infection. Upon completion of this activity, participants should be better able to: Recognize the burden of disease associated with RSV in older adults; Describe the clinical rationale for vaccines to prevent RSV in older adults; and Evaluate the latest clinical data for late-stage investigational RSV vaccines in older adults.